Harm Tiddens
Overview
Explore the profile of Harm Tiddens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Veer T, Andrinopoulou E, Braunstahl G, Charbonnier J, Kim V, Latisenko R, et al.
Thorax
. 2024 Dec;
80(2):105-108.
PMID: 39638548
In this cohort study involving 9399 current and former smokers from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease study, we assessed the relationship between artificial intelligence-quantified mucus plugs on...
2.
Short C, Semple T, Abkir M, Padley S, Rosenthal M, McNally P, et al.
J Appl Physiol (1985)
. 2024 Aug;
137(4):883-891.
PMID: 39116346
Multiple breath washout (MBW) has successfully assessed the silent lung zone particularly in cystic fibrosis lung disease, however, it is limited to the communicating lung only. There are a number...
3.
McNally P, Davies J, Ciet P, Tiddens H
Am J Respir Crit Care Med
. 2024 Feb;
209(8):1039-1040.
PMID: 38354409
No abstract available.
4.
van den Bosch W, Jacobs N, Tiddens H, van de Vathorst S
BMJ Open Respir Res
. 2024 Feb;
11(1).
PMID: 38307629
The tobacco industry is accountable for an annual global death toll of approximately 8 million people and cigarette smoking is the foremost risk factor for several types of cancer. In...
5.
Lv Q, Gallardo-Estrella L, Andrinopoulou E, Chen Y, Charbonnier J, Sandvik R, et al.
Thorax
. 2023 Sep;
79(1):13-22.
PMID: 37734952
Background: Cystic fibrosis (CF) lung disease is characterised by progressive airway wall thickening and widening. We aimed to validate an artificial intelligence-based algorithm to assess dimensions of all visible bronchus-artery...
6.
Gilchrist F, Bui S, Gartner S, McColley S, Tiddens H, Ruiz G, et al.
J Cyst Fibros
. 2023 Jul;
23(1):80-86.
PMID: 37455237
Background: Antibiotic eradication therapies recommended for newly isolated Pseudomonas aeruginosa (Pa) in people with cystic fibrosis (pwCF) can be burdensome. ALPINE2 compared the efficacy and safety of a shortened 14-day...
7.
Smits B, Goldacker S, Seneviratne S, Malphettes M, Longhurst H, Mohamed O, et al.
J Allergy Clin Immunol
. 2023 Jan;
152(2):528-537.
PMID: 36587851
Background: Granulomatous and lymphocytic interstitial lung disease (gl-ILD) is a major cause of morbidity and mortality among patients with common variable immunodeficiency. Corticosteroids are recommended as first-line treatment for gl-ILD,...
8.
Svedberg M, Imberg H, Gustafsson P, Tiddens H, Davies G, Lindblad A
Thorax
. 2022 Mar;
78(2):176-182.
PMID: 35277449
No abstract available.
9.
Aliberti S, Goeminne P, ODonnell A, Aksamit T, Al-Jahdali H, Barker A, et al.
Lancet Respir Med
. 2021 Sep;
10(3):298-306.
PMID: 34570994
Bronchiectasis refers to both a clinical disease and a radiological appearance that has multiple causes and can be associated with a range of conditions. Disease heterogeneity and the absence of...
10.
Elders B, Ciet P, Tiddens H, van den Bosch W, Wielopolski P, Pullens B
Thorax
. 2020 Oct;
76(1):44-52.
PMID: 33122446
Rationale: Paediatric laryngotracheal stenosis (LTS) is often successfully corrected with open airway surgery. However, respiratory and vocal sequelae frequently remain. Clinical care and surgical interventions could be improved with better...